FIELD: medicine; biotechnologies.
SUBSTANCE: substance of invention involved reconstructed virus membrane with lipid bilayer containing fused virus protein and amphiphilic adjuvant represented with lipopeptide. Further invention refers to production procedures of reconstructed virus membranes manifesting fused membrane activity, that are lipid bilayer membranes preferably containing natural virus lipids, fused virus protein, optionally, one or more additional antigens and amphiphilic adjuvants. Besides invention refers to pharmaceutical compositions containing these reconstructed virus membranes.
EFFECT: intensified immune response.
13 cl, 6 ex, 1 tbl, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF PRODUCING ADJUVANTED VIROSOME AND ADJUVANTED VIROSOMES, OBTAINED BY SAID METHODS | 2014 |
|
RU2694367C2 |
| VIROSOMES CONTAINING HEMAGGLUTININ EXTRACTED FROM INFLUENZA VIRUS PRODUCED IN THE CELL LINES, COMPOSITIONS, CONTAINING SAID VIROSOMES, MEANS OF MANUFACTURING AND APPLICATIONS | 2008 |
|
RU2441647C2 |
| STIMULATION OF IMMUNE RESPONSE BY ENANTIOMERS OF CATIONIC LIPIDS | 2009 |
|
RU2530555C2 |
| IMMUNOGENIC COMPOSITION AND METHOD OF FUSED PROTEIN VACCINE DEVELOPMENT | 2004 |
|
RU2407749C2 |
| SPHINGOID POLYALKYLAMINE CONJUGATES FOR BACTERINATION | 2004 |
|
RU2361577C2 |
| METHOD OF PRODUCING VACCINE ANTIGENS, OBTAINED VACCINE ANTIGENS AND USE THEREOF | 2015 |
|
RU2703147C2 |
| PROLINE-RICH PEPTIDES PROTECTING AGAINST S.PNEUMONIAE | 2014 |
|
RU2737638C2 |
| ORALLY DISPERSABLE VACCINE CONTAINING VIROSOMES | 2019 |
|
RU2808276C2 |
| VIRUS-LIKE PARTICLES CONTAINING TARGET PROTEINS FUSED WITH COAT PROTEINS OF PLANT VIRUSES | 2010 |
|
RU2571223C2 |
| VACCINE COMPOSITIONS WITH CATION LIPIDES AND METHODS OF APPLICATION | 2013 |
|
RU2649365C2 |
